Fabian Kiessling (born 16 August 1972) is a German radiologist, university lecturer and author as well as a scientist in the field of molecular imaging.

Academic career

Fabian Kiessling was born Mannheim and graduated high school in 1992 in Heidelberg and studied medicine at Heidelberg University. After his elective period at the district hospital in Schwetzingen, he completed his studies with the second state examination and was awarded his doctorate in 2001 in Internal Medicine.[1]

From 2001 he worked in the Dept. of Oncological Diagnostics and Therapy at the German Cancer Research Center (DKFZ) in Heidelberg and stayed there as an intern until 2002.

In 2003 he moved to the Dept. of Oncology at the Thorax Clinic Heidelberg and in parallel became head of the Molecular Diagnostics group in the Dept. of Medical Physics in Radiology at the DKFZ. In 2006, he became the Junior Group Leader for 'Molecular Imaging' at the DKFZ and habilitated in Experimental Radiology at the Heidelberg University.

2007 he completed his education as a medical specialist in diagnostic radiology.

In March 2008 he was appointed as full professor and director of the Institute for Experimental Molecular Imaging (ExMI) at RWTH Aachen (Rheinisch-Westfälische Technische Hochschule Aachen). He is also one of the directors of the RWTH Helmholtz Institute for Biomedical Engineering.

Boards and Chairs

  • 2005-2012 - Speaker of the section Molecular Imaging of the working group Methodology and Research of the Deutsche Röntgengesellschaft
  • 2008-2012 - chairman of the abovementioned working group
  • 2012-onwards - Served in the council of European Society for Molecular Imaging (ESMI)
  • 2014-2015 - Chairman of the “Molecular Imaging Subcommittee” of the European Society of Radiology
  • 2016 - Program chair of the World Molecular Imaging Congress in New York
  • 2018 - Member of the Board of Trustees of the World Molecular Imaging Society (WMIS)
  • Current - WMIC Fellow
  • Current - Member of the executive board of the Deutsche Gesellschaft für Biomedizinische Technik (German)
  • Current - President of the ESMI (European Society for Molecular Imaging)

Research

The research of Fabian Kiessling focusses on the development of new imaging methods and probes, with a particular focus on oncology and diseases that go along with angiogenesis and vascular remodeling. He worked on the imaging technique volumetric area detector computed tomography[2] and published the new ultrasound technique Motion Model Ultrasound Localization Microscopy together with his colleague Georg Schmitz. The ultrasound technique was preclinically tested and used in a first clinical application.[3] Both methods allow non-invasive imaging of hair-thin blood vessels in tumors and other tissues. In his translational research, imaging-guided therapy plays an important role including the investigation of biological barriers for drug delivery and the development of strategies to overcome these barriers by the use of nanomedicines, drug delivery systems, and other therapeutics.

Awards

  • 2006 Dr. Emil Salzer Prize[4]
  • 2006 Richtzenhain Prize

Honors

Selected publications

Books edited

  • Small animal imaging : basics and practical guide. Fabian Kiessling, Bernd J. Pichler, Peter Hauff. Berlin: Springer. 2011. ISBN 978-3-642-12945-2. OCLC 695389190.{{cite book}}: CS1 maint: others (link)
  • Comprehensive biomedical physics. Anders Brahme. Amsterdam. 2014. ISBN 978-0-444-53632-7. OCLC 907794199.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
  • Small animal imaging : basics and practical guide. Fabian Kiessling, Bernd J. Pichler, Peter Hauff (Second ed.). Cham, Switzerland. 2017. ISBN 978-3-319-42202-2. OCLC 987910980.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
  • Molecular imaging in oncology. Otmar Schober, Fabian Kiessling, Jürgen Debus (Second ed.). Cham, Switzerland. 2020. ISBN 978-3-030-42618-7. OCLC 1162846437.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)

Most-cited peer-reviewed journal articles

  • T Lammers, F Kiessling, WE Hennink, G Storm/ Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress. Journal of controlled release 161 (2), 175-187 (2012).
  • T Lammers, S Aime, WE Hennink, G Storm, F Kiessling. Theranostic Nanomedicine. Accounts of chemical research 44 (10), 1029-1038 (2011)

References

  1. ↑ Abstract of the dissertation "ECV 304: a polar human endothelial cell line?") (PDF; 9 kB)
  2. ↑ Kiessling, F.; Greschus, S.; Lichy, M. P.; Bock, M.; Fink, C.; Vosseler, S.; Moll, J.; Mueller, M. M.; Fusenig, N. E.; Traupe, H.; Semmler, W. (2004). "Volumetric computed tomography (VCT): A new technology for noninvasive, high-resolution monitoring of tumor angiogenesis". Nature Medicine. 10 (10): 1133–1138. doi:10.1038/nm1101. PMID 15361864. S2CID 7868388.
  3. ↑ T. Opacic, S. Dencks and others: Motion model ultrasound localization microscopy for preclinical and clinical multiparametric tumor characterization. In: Nature Communications. Volume 9, Number 1, April 2018, p. 1527, doi:10.1038/s41467-018-03973-8, PMID 29670096, {{PMC 5906644.
  4. ↑ "Cancer Researchers Quartet receives Richtzenhain and Dr. Emil Salzer Prizes". Archived from the original on 2016-03-04. Retrieved 2020-09-04.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.